Completing data — refresh the page later to see the latest
1955-68-6NC(CC(=O)NO)C(=O)OZBYVTTSIVDYQSO-UHFFFAOYSA-NRN given refers to (DL)-isomer
1955-68-6、20154-32-9CHEMBL216856Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Substances that inhibit or prevent the proliferation of NEOPLASMS.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
DescriptionHydroxylated lecithin, also known as b-L-aspartylhydroxamate or b-aspartohydroxamic acid, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Based on a literature review a small amount of articles have been published on Hydroxylated lecithin.
UsesL-ASPARTIC ACID BETA-HYDROXAMATE can be used as organic synthesis intermediate and pharmaceutical intermediate, mainly used in laboratory research and development process and chemical and pharmaceutical production process.
Loading…
DefinitionChEBI: Beta-L-aspartylhydroxamic acid is a non-proteinogenic L-alpha-amino acid that is L-asparagine hydroxylated at N-4. It is a hydroxamic acid, a L-asparagine derivative and a non-proteinogenic L-alpha-amino acid. It is a tautomer of a beta-L-aspartylhydroxamic acid zwitterion.